Co-founded by U of T alumni, BenchSci selected for inaugural CB Insights advanced manufacturing 50 list

July 28, 2022 by Betakit Charlize Alcaraz

BenchSci is a biotech startup that uses machine learning models to help expedite the research and discovery process for medicinal drugs. The company was founded in 2015 by Tom Leung (HBSc 2006), David Q Chen (HBSc 2007), Elvis Wianda, and Liran Belenzon. It launched commercially in July 2017, and since then, BenchSci’s products have been used by sixteen of the top 20 pharmaceutical companies, including Eli Lilly, Sanofi, Moderna, and AstraZeneca.

Read the full article here